ASTROCYTOMA

作品数:45被引量:65H指数:5
导出分析报告
相关领域:医药卫生生物学更多>>
相关作者:叶飞易伟薛德麟雷霆杨忠更多>>
相关机构:华中科技大学德阳市人民医院清华大学玉泉医院第三军医大学更多>>
相关期刊:《Open Journal of Modern Neurosurgery》《材料科学与工程(中英文A版)》《Journal of Clinical and Nursing Research》《中国神经肿瘤杂志》更多>>
相关基金:国家自然科学基金国家重点基础研究发展计划更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in Glioblastoma Multiforme:a systematic review going beyond pathologic implications
《Oncology Research》2024年第8期1239-1256,共18页DIMITRA P.VAGELI PANAGIOTIS G.DOUKAS KERASIA GOUPOU ANTONIOS D.BENOS KYRIAKI ASTARA KONSTANTINA ZACHAROULI SOTIRIS SOTIRIOU MARIA IOANNOU 
Glioblastoma multiforme(GBM)is an aggressive primary brain tumor characterized by extensive heterogeneity and vascular proliferation.Hypoxic conditions in the tissue microenvironment are considered a pivotal player le...
关键词:Glioblastoma multiforme(GBM) Astrocytoma Grade III Astrocytoma Grade IV Hypoxia-inducible factor 1alpha(HIF-1α) Vascular endothelial growth factor(VEGF) 
Current challenges in the treatment of gliomas:The molecular era
《World Journal of Clinical Oncology》2024年第8期982-986,共5页Castalia Fernández Juan Zafra-Martín Felipe Couñago 
Gliomas originate from glial cells in the central nervous system.Approximately 80%-85%of malignant brain tumors in adults are gliomas.The most common central nervous system tumor in children is low-grade pediatric gli...
关键词:GLIOMAS CHEMOTHERAPY RADIOTHERAPY Isocitrate dehydrogenase-type mutant Pediatric gliomas ASTROCYTOMA OLIGODENDROGLIOMA 1p/19q-codeleted 
The interplay mechanism between IDH mutation, MGMT-promoter methylation, and PRMT5 activity in the progression of grade 4 astrocytoma: unraveling the complex triad theory
《Oncology Research》2024年第6期1037-1045,共9页MAHER KURDI ALAA ALKHOTANI ABDULRAHMAN SABBAGH EYAD FAIZO AHMED I.LARY AHMED K.BAMAGA MAJID ALMANSOURI BADR HAFIZ THAMER ALSHARIF SALEH BAEESA 
Background:The dysregulation of Isocitrate dehydrogenase(IDH)and the subsequent production of 2-Hydroxyglutrate(2HG)may alter the expression of epigenetic proteins in Grade 4 astrocytoma.The interplay mechanism betwee...
关键词:Grade 4 astrocytoma GLIOBLASTOMA Isocitrate dehydrogenase(IDH) O-6-methylguanine-DNA methyltransferase(MGMT) Protein methyltransferase proteins-5(PRMT5) Progression-free survival(PFS) 
Updates on management of gliomas in the molecular age被引量:2
《World Journal of Clinical Oncology》2024年第2期178-194,共17页Ali Ahmed Mohamed Rakan Alshaibi Steven Faragalla Youssef Mohamed Brandon Lucke-Wold 
Gliomas are primary brain tumors derived from glial cells of the central nervous system,afflicting both adults and children with distinct characteristics and therapeutic challenges.Recent developments have ushered in ...
关键词:GLIOMAS Chemotherapy RADIOTHERAPY Isocitrate dehydrogenase type mutant Pediatric gliomas ASTROCYTOMA OLIGODENDROGLIOMA 1p/19q-codeleted 
Stromal and Tumor Glioma-derived Cells with Similar Characteristics Have Differences in α-Smooth Muscle Actin Expression and Localization
《Journal of Oncology Research》2021年第2期8-21,共14页I.Gin I.Chistyakova V.Zenin S.Koshkin A.Musorina Y.Lahina G.Timin V.Pospelov S.Prikhodko A.Petukhov E.Tolkunova 
The design of this study and analysis of data were fi­nancially supported by the grants from Russian Science Foundation(No.18-75-10076)and by RFBR(No.19-315-51035).
Gliomas are solid brain tumors composed of tumor cells and recruited heterogenic stromal components.The study of the interactions between the perivascular niche and its surrounding cells is of great value in unravelin...
关键词:OLIGODENDROGLIOMA ASTROCYTOMA Primary cell cultures Tumor microenvironment MYOFIBROBLASTS Extracellular matrix 
Case Report: Anaplastic Astrocytoma Treated with Postoperative Radiotherapy Using Flattening Filter-Free Volumetric Arc Therapy (FFF-VMAT) during Pregnancy—Acceptable Fetal Dosimetry
《Journal of Cancer Therapy》2020年第11期738-744,共7页Tomoyuki Noyama Wataru Takahashi Yuki Nozawa Kanabu Nawa Hideomi Yamashita Osamu Abe Keiichi Nakagawa 
Background: Postoperative irradiation for brain tumor in pregnant women is a matter of concern.
《Journal of Clinical and Nursing Research》2019年第5期9-13,共5页Xiangyi Yin Xiaowen Zhu Xianlan Meng Lihui Zhou 
Objective:To investigate the effect and value of perioperative nursing intervention on postoperative recurrent grade II-I left frontal astrocytoma.Method:Nursing care procedures:left frontal lobe of the patient was oc...
关键词:POSTOPERATIVE RECURRENT GRADE Ⅱ-I ASTROCYTOMA PERIOPERATIVE period Nursing care of complications Quality life 
Synthesis of Amine Terminated Pegylated Iron Oxide Nanoparticles for Prospective Astrocytoma Resection Grade Improvement
《材料科学与工程(中英文A版)》2019年第1期25-37,共13页Isaias Eduardo Hernández-Verdin María Luisa Martínez Alejandro Miranda-González Mónica Alicia Sierra del Río Oracio Serrano-Torres Mario Avila-Rodríguez 
Having a survival rate to 5 years of only 3%,Glioblastoma’s(GBM)main treatment is surgical excision.Iron oxide nanoparticles have been proved to be a magnetic resonance imaging contrast agent and,if synthesized and t...
关键词:Iron oxide nanoparticles SILANIZATION PEGYLATION ASTROCYTOMA 
Recent Techniques in Management of Lumbosacral Region Tumours: A Prospective Comparative Study
《Open Journal of Modern Neurosurgery》2018年第2期239-249,共11页Mostafa Abd Elsamea Mohamed Shaaban Ahmed Taha 
Background: The lumbosacral plexus consists of the ventral rami from the L2 to S3 nerve roots, with some additions from the L1 and S4 nerve roots as well. The standard treatment for spinal cord compression is urgent s...
关键词:Lambosacral LESION ASTROCYTOMA EPENDYMOMA 
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas—Final Report (Protocol BT-13)被引量:1
《Journal of Cancer Therapy》2016年第12期837-850,共14页Stanislaw R. Burzynski Tomasz J. Janicki Gregory S. Burzynski 
Nonresectable Low-Grade Astrocytomas (LGA) can compromise function and threaten life. For the majority of patients, the most appropriate strategy is initial chemotherapy followed by Radiation Therapy (RT). Since curat...
关键词:Antineoplastons A10 and AS2-1 ASTROCYTOMA Low-Grade Astrocytoma Low-Grade Glioma Pediatric Brain Tumors Phase II Clinical Trial